Repairing The Broken Market For Antibiotic Innovation

Approval and Withdrawal of New Antibiotics and other Antiinfectives in the U.S., 1980–2009

(2015) Kevin Outterson et al.   JOURNAL OF LAW MEDICINE & ETHICS

The evolution of the regulatory framework for antibacterial agents

(2014) John H. Rex et al.   Annals of the New York Academy of Sciences

Era Of Faster FDA Drug Approval Has Also Seen Increased Black-Box Warnings And Market Withdrawals

(2014) Cassie Frank et al.   HEALTH AFFAIRS

UK and European Union public and charitable funding from 2008 to 2013 for bacteriology and antibiotic research in the UK: an observational study

(2014) Eilis C Bragginton et al.   LANCET INFECTIOUS DISEASES

Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data

(2014) Thomas P Van Boeckel et al.   LANCET INFECTIOUS DISEASES

Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection

(2014) Helen W. Boucher et al.   NEW ENGLAND JOURNAL OF MEDICINE

US incentive scheme for neglected diseases: a good idea gone wrong?

(2014) P. Doshi   BMJ-British Medical Journal

Clarifications about add-on payments for fidaxomicin

(2013) H. Shah et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Collective action and individual choice: rethinking how we regulate narcotics and antibiotics

(2013) Jonny Anomaly   JOURNAL OF MEDICAL ETHICS

Research Spotlight: The TB Alliance: overcoming challenges to chart the future course of TB drug development

(2011) Ann Ginsberg   Future Medicinal Chemistry

Fidaxomicin versus Vancomycin forClostridium difficileInfection

(2011) Thomas J. Louie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis

(2009) Heather E. Hsu et al.   NEW ENGLAND JOURNAL OF MEDICINE